logo-loader
Arcturus Therapeutics

Full interview: Arcturus Therapeutics working to 'transform the pharmaceutical industry' with its therapeutics

Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) CEO Joseph Payne tells Proactive that the company which specializes in developing messenger RNA medicine for rare diseases, is working towards 'transforming the pharmaceutical industry' with its therapeutics.

Payne says San Diego-based Arcturus has four therapeutics in pre-clinical studies, including its lead therapeutics LUNAR-CF and LUNAR-OTC. He is pleased with how its 2Q financial highlights are propelling these programs into the clinic.

Quick facts: Arcturus Therapeutics

Price: $13.22

Market: NASDAQ
Market Cap: $188.71 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Alchemist sees big market in China for medical cannabis sales

Alchemist (CSE: AMS) CEO Paul Mann and Vice President of Business Development, Asia Pacific Johnson Lee joined Steve Darling from Proactive Vancouver to discuss Alchemist looking for opportunities for cannabis in the emerging cannabis market.  Mann and Lee talk about what the industry...

1 day, 14 hours ago

2 min read